TrialNaunyn-Schmiedeberg's archives of pharmacology2024

The effects of empagliflozin on ventricular arrhythmias in heart failure patients with an implantable cardioverter-defibrillator: a double-blind randomized controlled trial.

Farshad Abedi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.